Skip to content

Clinical trials

Observational Multiple Myeloma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Country / region: Germany Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20104
20121
20142
20151
20162
20172
20191
20203
20212
20223
20235
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
iOMEDICO AG7
Bristol-Myers Squibb2
Celgene2
Janssen Pharmaceutica N.V., Belgium2
Janssen-Cilag Ltd.2
Takeda2
AIO-Studien-gGmbH1
AbbVie1
Cankado GmbH1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma31
Breast Neoplasms2
Infections2
Leukemia, B-Cell2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Follicular2
Lymphoma, Non-Hodgkin2
Neoplasms2
Recurrence2
Blast Crisis1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.